Medical Care
Global Human 293 (HEK 293) Cells Market Research Report 2025
- Aug 26, 25
- ID: 468007
- Pages: 106
- Figures: 107
- Views: 1
The global market for Human 293 (HEK 293) Cells was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 286 million by 2031, growing at a CAGR of 8.3% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human 293 (HEK 293) Cells competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global production of HEK 293 cells reached 215,000 vials, with an average selling price of US$716 per vial. HEK 293 cells are an immortalized cell line derived from human embryonic kidney (HEK) cells. They were originally derived through adenovirus type 5 (Ad5) transduction. They are easy to culture, have high transfection efficiency, and are highly compatible with exogenous gene expression. They are widely used in recombinant protein and monoclonal antibody production, adenoviral and lentiviral vector preparation, gene therapy product development, vaccine development, drug screening, and toxicity testing. The "293" designation refers to the cell line derived from the 293rd experiment.
North American market for Human 293 (HEK 293) Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human 293 (HEK 293) Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human 293 (HEK 293) Cells include Altogen Biosystems, ATCC, Synthego, Thermo Fisher Scientific, Beckman Coulter, Sigma Aldrich, Promega, Kerafast, InvivoGen, Innoprot, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human 293 (HEK 293) Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human 293 (HEK 293) Cells.
The Human 293 (HEK 293) Cells market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human 293 (HEK 293) Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human 293 (HEK 293) Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Altogen Biosystems
ATCC
Synthego
Thermo Fisher Scientific
Beckman Coulter
Sigma Aldrich
Promega
Kerafast
InvivoGen
Innoprot
Takara Bio
BPS Bioscience
ACROBiosystems Group
Porton Pharma Solutions
Ubigene Biosciences
Wuhan Pricella Biotechnology
Segment by Type
HEK293T
HEK293E
HEK293F
HEK293S
Others
Segment by Application
Recombinant Protein Production
Gene Therapy
Vaccine Development
Drug Screening
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human 293 (HEK 293) Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human 293 (HEK 293) Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human 293 (HEK 293) Cells competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global production of HEK 293 cells reached 215,000 vials, with an average selling price of US$716 per vial. HEK 293 cells are an immortalized cell line derived from human embryonic kidney (HEK) cells. They were originally derived through adenovirus type 5 (Ad5) transduction. They are easy to culture, have high transfection efficiency, and are highly compatible with exogenous gene expression. They are widely used in recombinant protein and monoclonal antibody production, adenoviral and lentiviral vector preparation, gene therapy product development, vaccine development, drug screening, and toxicity testing. The "293" designation refers to the cell line derived from the 293rd experiment.
North American market for Human 293 (HEK 293) Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human 293 (HEK 293) Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human 293 (HEK 293) Cells include Altogen Biosystems, ATCC, Synthego, Thermo Fisher Scientific, Beckman Coulter, Sigma Aldrich, Promega, Kerafast, InvivoGen, Innoprot, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human 293 (HEK 293) Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human 293 (HEK 293) Cells.
The Human 293 (HEK 293) Cells market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human 293 (HEK 293) Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human 293 (HEK 293) Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Altogen Biosystems
ATCC
Synthego
Thermo Fisher Scientific
Beckman Coulter
Sigma Aldrich
Promega
Kerafast
InvivoGen
Innoprot
Takara Bio
BPS Bioscience
ACROBiosystems Group
Porton Pharma Solutions
Ubigene Biosciences
Wuhan Pricella Biotechnology
Segment by Type
HEK293T
HEK293E
HEK293F
HEK293S
Others
Segment by Application
Recombinant Protein Production
Gene Therapy
Vaccine Development
Drug Screening
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human 293 (HEK 293) Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human 293 (HEK 293) Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Human 293 (HEK 293) Cells Market Overview
1.1 Product Definition
1.2 Human 293 (HEK 293) Cells by Type
1.2.1 Global Human 293 (HEK 293) Cells Market Value Comparison by Type (2024 VS 2031)
1.2.2 HEK293T
1.2.3 HEK293E
1.2.4 HEK293F
1.2.5 HEK293S
1.2.6 Others
1.3 Human 293 (HEK 293) Cells by Application
1.3.1 Global Human 293 (HEK 293) Cells Market Value by Application (2024 VS 2031)
1.3.2 Recombinant Protein Production
1.3.3 Gene Therapy
1.3.4 Vaccine Development
1.3.5 Drug Screening
1.3.6 Others
1.4 Global Human 293 (HEK 293) Cells Market Size Estimates and Forecasts
1.4.1 Global Human 293 (HEK 293) Cells Revenue 2020-2031
1.4.2 Global Human 293 (HEK 293) Cells Sales 2020-2031
1.4.3 Global Human 293 (HEK 293) Cells Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human 293 (HEK 293) Cells Market Competition by Manufacturers
2.1 Global Human 293 (HEK 293) Cells Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human 293 (HEK 293) Cells Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human 293 (HEK 293) Cells Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human 293 (HEK 293) Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human 293 (HEK 293) Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human 293 (HEK 293) Cells, Product Type & Application
2.7 Global Key Manufacturers of Human 293 (HEK 293) Cells, Date of Enter into This Industry
2.8 Global Human 293 (HEK 293) Cells Market Competitive Situation and Trends
2.8.1 Global Human 293 (HEK 293) Cells Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human 293 (HEK 293) Cells Players Market Share by Revenue
2.8.3 Global Human 293 (HEK 293) Cells Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human 293 (HEK 293) Cells Market Scenario by Region
3.1 Global Human 293 (HEK 293) Cells Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human 293 (HEK 293) Cells Sales by Region: 2020-2031
3.2.1 Global Human 293 (HEK 293) Cells Sales by Region: 2020-2025
3.2.2 Global Human 293 (HEK 293) Cells Sales by Region: 2026-2031
3.3 Global Human 293 (HEK 293) Cells Revenue by Region: 2020-2031
3.3.1 Global Human 293 (HEK 293) Cells Revenue by Region: 2020-2025
3.3.2 Global Human 293 (HEK 293) Cells Revenue by Region: 2026-2031
3.4 North America Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.4.1 North America Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.4.3 North America Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.5.1 Europe Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.5.3 Europe Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human 293 (HEK 293) Cells Market Facts & Figures by Region
3.6.1 Asia Pacific Human 293 (HEK 293) Cells Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human 293 (HEK 293) Cells Sales by Region (2020-2031)
3.6.3 Asia Pacific Human 293 (HEK 293) Cells Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.7.1 Latin America Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.7.3 Latin America Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human 293 (HEK 293) Cells Sales by Type (2020-2031)
4.1.1 Global Human 293 (HEK 293) Cells Sales by Type (2020-2025)
4.1.2 Global Human 293 (HEK 293) Cells Sales by Type (2026-2031)
4.1.3 Global Human 293 (HEK 293) Cells Sales Market Share by Type (2020-2031)
4.2 Global Human 293 (HEK 293) Cells Revenue by Type (2020-2031)
4.2.1 Global Human 293 (HEK 293) Cells Revenue by Type (2020-2025)
4.2.2 Global Human 293 (HEK 293) Cells Revenue by Type (2026-2031)
4.2.3 Global Human 293 (HEK 293) Cells Revenue Market Share by Type (2020-2031)
4.3 Global Human 293 (HEK 293) Cells Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human 293 (HEK 293) Cells Sales by Application (2020-2031)
5.1.1 Global Human 293 (HEK 293) Cells Sales by Application (2020-2025)
5.1.2 Global Human 293 (HEK 293) Cells Sales by Application (2026-2031)
5.1.3 Global Human 293 (HEK 293) Cells Sales Market Share by Application (2020-2031)
5.2 Global Human 293 (HEK 293) Cells Revenue by Application (2020-2031)
5.2.1 Global Human 293 (HEK 293) Cells Revenue by Application (2020-2025)
5.2.2 Global Human 293 (HEK 293) Cells Revenue by Application (2026-2031)
5.2.3 Global Human 293 (HEK 293) Cells Revenue Market Share by Application (2020-2031)
5.3 Global Human 293 (HEK 293) Cells Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Altogen Biosystems
6.1.1 Altogen Biosystems Company Information
6.1.2 Altogen Biosystems Description and Business Overview
6.1.3 Altogen Biosystems Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Altogen Biosystems Human 293 (HEK 293) Cells Product Portfolio
6.1.5 Altogen Biosystems Recent Developments/Updates
6.2 ATCC
6.2.1 ATCC Company Information
6.2.2 ATCC Description and Business Overview
6.2.3 ATCC Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ATCC Human 293 (HEK 293) Cells Product Portfolio
6.2.5 ATCC Recent Developments/Updates
6.3 Synthego
6.3.1 Synthego Company Information
6.3.2 Synthego Description and Business Overview
6.3.3 Synthego Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Synthego Human 293 (HEK 293) Cells Product Portfolio
6.3.5 Synthego Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific Human 293 (HEK 293) Cells Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Beckman Coulter
6.5.1 Beckman Coulter Company Information
6.5.2 Beckman Coulter Description and Business Overview
6.5.3 Beckman Coulter Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beckman Coulter Human 293 (HEK 293) Cells Product Portfolio
6.5.5 Beckman Coulter Recent Developments/Updates
6.6 Sigma Aldrich
6.6.1 Sigma Aldrich Company Information
6.6.2 Sigma Aldrich Description and Business Overview
6.6.3 Sigma Aldrich Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sigma Aldrich Human 293 (HEK 293) Cells Product Portfolio
6.6.5 Sigma Aldrich Recent Developments/Updates
6.7 Promega
6.7.1 Promega Company Information
6.7.2 Promega Description and Business Overview
6.7.3 Promega Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Promega Human 293 (HEK 293) Cells Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Kerafast
6.8.1 Kerafast Company Information
6.8.2 Kerafast Description and Business Overview
6.8.3 Kerafast Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kerafast Human 293 (HEK 293) Cells Product Portfolio
6.8.5 Kerafast Recent Developments/Updates
6.9 InvivoGen
6.9.1 InvivoGen Company Information
6.9.2 InvivoGen Description and Business Overview
6.9.3 InvivoGen Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.9.4 InvivoGen Human 293 (HEK 293) Cells Product Portfolio
6.9.5 InvivoGen Recent Developments/Updates
6.10 Innoprot
6.10.1 Innoprot Company Information
6.10.2 Innoprot Description and Business Overview
6.10.3 Innoprot Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Innoprot Human 293 (HEK 293) Cells Product Portfolio
6.10.5 Innoprot Recent Developments/Updates
6.11 Takara Bio
6.11.1 Takara Bio Company Information
6.11.2 Takara Bio Description and Business Overview
6.11.3 Takara Bio Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takara Bio Human 293 (HEK 293) Cells Product Portfolio
6.11.5 Takara Bio Recent Developments/Updates
6.12 BPS Bioscience
6.12.1 BPS Bioscience Company Information
6.12.2 BPS Bioscience Description and Business Overview
6.12.3 BPS Bioscience Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPS Bioscience Human 293 (HEK 293) Cells Product Portfolio
6.12.5 BPS Bioscience Recent Developments/Updates
6.13 ACROBiosystems Group
6.13.1 ACROBiosystems Group Company Information
6.13.2 ACROBiosystems Group Description and Business Overview
6.13.3 ACROBiosystems Group Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ACROBiosystems Group Human 293 (HEK 293) Cells Product Portfolio
6.13.5 ACROBiosystems Group Recent Developments/Updates
6.14 Porton Pharma Solutions
6.14.1 Porton Pharma Solutions Company Information
6.14.2 Porton Pharma Solutions Description and Business Overview
6.14.3 Porton Pharma Solutions Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Porton Pharma Solutions Human 293 (HEK 293) Cells Product Portfolio
6.14.5 Porton Pharma Solutions Recent Developments/Updates
6.15 Ubigene Biosciences
6.15.1 Ubigene Biosciences Company Information
6.15.2 Ubigene Biosciences Description and Business Overview
6.15.3 Ubigene Biosciences Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ubigene Biosciences Human 293 (HEK 293) Cells Product Portfolio
6.15.5 Ubigene Biosciences Recent Developments/Updates
6.16 Wuhan Pricella Biotechnology
6.16.1 Wuhan Pricella Biotechnology Company Information
6.16.2 Wuhan Pricella Biotechnology Description and Business Overview
6.16.3 Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Product Portfolio
6.16.5 Wuhan Pricella Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human 293 (HEK 293) Cells Industry Chain Analysis
7.2 Human 293 (HEK 293) Cells Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human 293 (HEK 293) Cells Production Mode & Process Analysis
7.4 Human 293 (HEK 293) Cells Sales and Marketing
7.4.1 Human 293 (HEK 293) Cells Sales Channels
7.4.2 Human 293 (HEK 293) Cells Distributors
7.5 Human 293 (HEK 293) Cells Customer Analysis
8 Human 293 (HEK 293) Cells Market Dynamics
8.1 Human 293 (HEK 293) Cells Industry Trends
8.2 Human 293 (HEK 293) Cells Market Drivers
8.3 Human 293 (HEK 293) Cells Market Challenges
8.4 Human 293 (HEK 293) Cells Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Human 293 (HEK 293) Cells by Type
1.2.1 Global Human 293 (HEK 293) Cells Market Value Comparison by Type (2024 VS 2031)
1.2.2 HEK293T
1.2.3 HEK293E
1.2.4 HEK293F
1.2.5 HEK293S
1.2.6 Others
1.3 Human 293 (HEK 293) Cells by Application
1.3.1 Global Human 293 (HEK 293) Cells Market Value by Application (2024 VS 2031)
1.3.2 Recombinant Protein Production
1.3.3 Gene Therapy
1.3.4 Vaccine Development
1.3.5 Drug Screening
1.3.6 Others
1.4 Global Human 293 (HEK 293) Cells Market Size Estimates and Forecasts
1.4.1 Global Human 293 (HEK 293) Cells Revenue 2020-2031
1.4.2 Global Human 293 (HEK 293) Cells Sales 2020-2031
1.4.3 Global Human 293 (HEK 293) Cells Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human 293 (HEK 293) Cells Market Competition by Manufacturers
2.1 Global Human 293 (HEK 293) Cells Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human 293 (HEK 293) Cells Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human 293 (HEK 293) Cells Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human 293 (HEK 293) Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human 293 (HEK 293) Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human 293 (HEK 293) Cells, Product Type & Application
2.7 Global Key Manufacturers of Human 293 (HEK 293) Cells, Date of Enter into This Industry
2.8 Global Human 293 (HEK 293) Cells Market Competitive Situation and Trends
2.8.1 Global Human 293 (HEK 293) Cells Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human 293 (HEK 293) Cells Players Market Share by Revenue
2.8.3 Global Human 293 (HEK 293) Cells Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human 293 (HEK 293) Cells Market Scenario by Region
3.1 Global Human 293 (HEK 293) Cells Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human 293 (HEK 293) Cells Sales by Region: 2020-2031
3.2.1 Global Human 293 (HEK 293) Cells Sales by Region: 2020-2025
3.2.2 Global Human 293 (HEK 293) Cells Sales by Region: 2026-2031
3.3 Global Human 293 (HEK 293) Cells Revenue by Region: 2020-2031
3.3.1 Global Human 293 (HEK 293) Cells Revenue by Region: 2020-2025
3.3.2 Global Human 293 (HEK 293) Cells Revenue by Region: 2026-2031
3.4 North America Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.4.1 North America Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.4.3 North America Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.5.1 Europe Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.5.3 Europe Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human 293 (HEK 293) Cells Market Facts & Figures by Region
3.6.1 Asia Pacific Human 293 (HEK 293) Cells Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human 293 (HEK 293) Cells Sales by Region (2020-2031)
3.6.3 Asia Pacific Human 293 (HEK 293) Cells Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.7.1 Latin America Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.7.3 Latin America Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human 293 (HEK 293) Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa Human 293 (HEK 293) Cells Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human 293 (HEK 293) Cells Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human 293 (HEK 293) Cells Sales by Type (2020-2031)
4.1.1 Global Human 293 (HEK 293) Cells Sales by Type (2020-2025)
4.1.2 Global Human 293 (HEK 293) Cells Sales by Type (2026-2031)
4.1.3 Global Human 293 (HEK 293) Cells Sales Market Share by Type (2020-2031)
4.2 Global Human 293 (HEK 293) Cells Revenue by Type (2020-2031)
4.2.1 Global Human 293 (HEK 293) Cells Revenue by Type (2020-2025)
4.2.2 Global Human 293 (HEK 293) Cells Revenue by Type (2026-2031)
4.2.3 Global Human 293 (HEK 293) Cells Revenue Market Share by Type (2020-2031)
4.3 Global Human 293 (HEK 293) Cells Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human 293 (HEK 293) Cells Sales by Application (2020-2031)
5.1.1 Global Human 293 (HEK 293) Cells Sales by Application (2020-2025)
5.1.2 Global Human 293 (HEK 293) Cells Sales by Application (2026-2031)
5.1.3 Global Human 293 (HEK 293) Cells Sales Market Share by Application (2020-2031)
5.2 Global Human 293 (HEK 293) Cells Revenue by Application (2020-2031)
5.2.1 Global Human 293 (HEK 293) Cells Revenue by Application (2020-2025)
5.2.2 Global Human 293 (HEK 293) Cells Revenue by Application (2026-2031)
5.2.3 Global Human 293 (HEK 293) Cells Revenue Market Share by Application (2020-2031)
5.3 Global Human 293 (HEK 293) Cells Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Altogen Biosystems
6.1.1 Altogen Biosystems Company Information
6.1.2 Altogen Biosystems Description and Business Overview
6.1.3 Altogen Biosystems Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Altogen Biosystems Human 293 (HEK 293) Cells Product Portfolio
6.1.5 Altogen Biosystems Recent Developments/Updates
6.2 ATCC
6.2.1 ATCC Company Information
6.2.2 ATCC Description and Business Overview
6.2.3 ATCC Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ATCC Human 293 (HEK 293) Cells Product Portfolio
6.2.5 ATCC Recent Developments/Updates
6.3 Synthego
6.3.1 Synthego Company Information
6.3.2 Synthego Description and Business Overview
6.3.3 Synthego Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Synthego Human 293 (HEK 293) Cells Product Portfolio
6.3.5 Synthego Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Company Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Scientific Human 293 (HEK 293) Cells Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Beckman Coulter
6.5.1 Beckman Coulter Company Information
6.5.2 Beckman Coulter Description and Business Overview
6.5.3 Beckman Coulter Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beckman Coulter Human 293 (HEK 293) Cells Product Portfolio
6.5.5 Beckman Coulter Recent Developments/Updates
6.6 Sigma Aldrich
6.6.1 Sigma Aldrich Company Information
6.6.2 Sigma Aldrich Description and Business Overview
6.6.3 Sigma Aldrich Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sigma Aldrich Human 293 (HEK 293) Cells Product Portfolio
6.6.5 Sigma Aldrich Recent Developments/Updates
6.7 Promega
6.7.1 Promega Company Information
6.7.2 Promega Description and Business Overview
6.7.3 Promega Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Promega Human 293 (HEK 293) Cells Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Kerafast
6.8.1 Kerafast Company Information
6.8.2 Kerafast Description and Business Overview
6.8.3 Kerafast Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kerafast Human 293 (HEK 293) Cells Product Portfolio
6.8.5 Kerafast Recent Developments/Updates
6.9 InvivoGen
6.9.1 InvivoGen Company Information
6.9.2 InvivoGen Description and Business Overview
6.9.3 InvivoGen Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.9.4 InvivoGen Human 293 (HEK 293) Cells Product Portfolio
6.9.5 InvivoGen Recent Developments/Updates
6.10 Innoprot
6.10.1 Innoprot Company Information
6.10.2 Innoprot Description and Business Overview
6.10.3 Innoprot Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Innoprot Human 293 (HEK 293) Cells Product Portfolio
6.10.5 Innoprot Recent Developments/Updates
6.11 Takara Bio
6.11.1 Takara Bio Company Information
6.11.2 Takara Bio Description and Business Overview
6.11.3 Takara Bio Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takara Bio Human 293 (HEK 293) Cells Product Portfolio
6.11.5 Takara Bio Recent Developments/Updates
6.12 BPS Bioscience
6.12.1 BPS Bioscience Company Information
6.12.2 BPS Bioscience Description and Business Overview
6.12.3 BPS Bioscience Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPS Bioscience Human 293 (HEK 293) Cells Product Portfolio
6.12.5 BPS Bioscience Recent Developments/Updates
6.13 ACROBiosystems Group
6.13.1 ACROBiosystems Group Company Information
6.13.2 ACROBiosystems Group Description and Business Overview
6.13.3 ACROBiosystems Group Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ACROBiosystems Group Human 293 (HEK 293) Cells Product Portfolio
6.13.5 ACROBiosystems Group Recent Developments/Updates
6.14 Porton Pharma Solutions
6.14.1 Porton Pharma Solutions Company Information
6.14.2 Porton Pharma Solutions Description and Business Overview
6.14.3 Porton Pharma Solutions Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Porton Pharma Solutions Human 293 (HEK 293) Cells Product Portfolio
6.14.5 Porton Pharma Solutions Recent Developments/Updates
6.15 Ubigene Biosciences
6.15.1 Ubigene Biosciences Company Information
6.15.2 Ubigene Biosciences Description and Business Overview
6.15.3 Ubigene Biosciences Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ubigene Biosciences Human 293 (HEK 293) Cells Product Portfolio
6.15.5 Ubigene Biosciences Recent Developments/Updates
6.16 Wuhan Pricella Biotechnology
6.16.1 Wuhan Pricella Biotechnology Company Information
6.16.2 Wuhan Pricella Biotechnology Description and Business Overview
6.16.3 Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Product Portfolio
6.16.5 Wuhan Pricella Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human 293 (HEK 293) Cells Industry Chain Analysis
7.2 Human 293 (HEK 293) Cells Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human 293 (HEK 293) Cells Production Mode & Process Analysis
7.4 Human 293 (HEK 293) Cells Sales and Marketing
7.4.1 Human 293 (HEK 293) Cells Sales Channels
7.4.2 Human 293 (HEK 293) Cells Distributors
7.5 Human 293 (HEK 293) Cells Customer Analysis
8 Human 293 (HEK 293) Cells Market Dynamics
8.1 Human 293 (HEK 293) Cells Industry Trends
8.2 Human 293 (HEK 293) Cells Market Drivers
8.3 Human 293 (HEK 293) Cells Market Challenges
8.4 Human 293 (HEK 293) Cells Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Human 293 (HEK 293) Cells Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human 293 (HEK 293) Cells Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human 293 (HEK 293) Cells Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human 293 (HEK 293) Cells Sales (K Vials) of Key Manufacturers (2020-2025)
Table 5. Global Human 293 (HEK 293) Cells Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human 293 (HEK 293) Cells Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human 293 (HEK 293) Cells Average Price (US$/Vials) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human 293 (HEK 293) Cells, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human 293 (HEK 293) Cells, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human 293 (HEK 293) Cells, Product Type & Application
Table 12. Global Key Manufacturers of Human 293 (HEK 293) Cells, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human 293 (HEK 293) Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human 293 (HEK 293) Cells as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human 293 (HEK 293) Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human 293 (HEK 293) Cells Sales by Region (2020-2025) & (K Vials)
Table 18. Global Human 293 (HEK 293) Cells Sales Market Share by Region (2020-2025)
Table 19. Global Human 293 (HEK 293) Cells Sales by Region (2026-2031) & (K Vials)
Table 20. Global Human 293 (HEK 293) Cells Sales Market Share by Region (2026-2031)
Table 21. Global Human 293 (HEK 293) Cells Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human 293 (HEK 293) Cells Revenue Market Share by Region (2020-2025)
Table 23. Global Human 293 (HEK 293) Cells Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human 293 (HEK 293) Cells Revenue Market Share by Region (2026-2031)
Table 25. North America Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 27. North America Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 28. North America Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 32. Europe Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 33. Europe Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human 293 (HEK 293) Cells Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human 293 (HEK 293) Cells Sales by Region (2020-2025) & (K Vials)
Table 37. Asia Pacific Human 293 (HEK 293) Cells Sales by Region (2026-2031) & (K Vials)
Table 38. Asia Pacific Human 293 (HEK 293) Cells Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human 293 (HEK 293) Cells Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 42. Latin America Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 43. Latin America Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 47. Middle East and Africa Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 48. Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human 293 (HEK 293) Cells Sales (K Vials) by Type (2020-2025)
Table 51. Global Human 293 (HEK 293) Cells Sales (K Vials) by Type (2026-2031)
Table 52. Global Human 293 (HEK 293) Cells Sales Market Share by Type (2020-2025)
Table 53. Global Human 293 (HEK 293) Cells Sales Market Share by Type (2026-2031)
Table 54. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human 293 (HEK 293) Cells Revenue Market Share by Type (2020-2025)
Table 57. Global Human 293 (HEK 293) Cells Revenue Market Share by Type (2026-2031)
Table 58. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Type (2020-2025)
Table 59. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Type (2026-2031)
Table 60. Global Human 293 (HEK 293) Cells Sales (K Vials) by Application (2020-2025)
Table 61. Global Human 293 (HEK 293) Cells Sales (K Vials) by Application (2026-2031)
Table 62. Global Human 293 (HEK 293) Cells Sales Market Share by Application (2020-2025)
Table 63. Global Human 293 (HEK 293) Cells Sales Market Share by Application (2026-2031)
Table 64. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human 293 (HEK 293) Cells Revenue Market Share by Application (2020-2025)
Table 67. Global Human 293 (HEK 293) Cells Revenue Market Share by Application (2026-2031)
Table 68. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Application (2020-2025)
Table 69. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Application (2026-2031)
Table 70. Altogen Biosystems Company Information
Table 71. Altogen Biosystems Description and Business Overview
Table 72. Altogen Biosystems Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 73. Altogen Biosystems Human 293 (HEK 293) Cells Product
Table 74. Altogen Biosystems Recent Developments/Updates
Table 75. ATCC Company Information
Table 76. ATCC Description and Business Overview
Table 77. ATCC Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 78. ATCC Human 293 (HEK 293) Cells Product
Table 79. ATCC Recent Developments/Updates
Table 80. Synthego Company Information
Table 81. Synthego Description and Business Overview
Table 82. Synthego Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 83. Synthego Human 293 (HEK 293) Cells Product
Table 84. Synthego Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Human 293 (HEK 293) Cells Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Beckman Coulter Company Information
Table 91. Beckman Coulter Description and Business Overview
Table 92. Beckman Coulter Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 93. Beckman Coulter Human 293 (HEK 293) Cells Product
Table 94. Beckman Coulter Recent Developments/Updates
Table 95. Sigma Aldrich Company Information
Table 96. Sigma Aldrich Description and Business Overview
Table 97. Sigma Aldrich Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 98. Sigma Aldrich Human 293 (HEK 293) Cells Product
Table 99. Sigma Aldrich Recent Developments/Updates
Table 100. Promega Company Information
Table 101. Promega Description and Business Overview
Table 102. Promega Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 103. Promega Human 293 (HEK 293) Cells Product
Table 104. Promega Recent Developments/Updates
Table 105. Kerafast Company Information
Table 106. Kerafast Description and Business Overview
Table 107. Kerafast Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 108. Kerafast Human 293 (HEK 293) Cells Product
Table 109. Kerafast Recent Developments/Updates
Table 110. InvivoGen Company Information
Table 111. InvivoGen Description and Business Overview
Table 112. InvivoGen Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 113. InvivoGen Human 293 (HEK 293) Cells Product
Table 114. InvivoGen Recent Developments/Updates
Table 115. Innoprot Company Information
Table 116. Innoprot Description and Business Overview
Table 117. Innoprot Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 118. Innoprot Human 293 (HEK 293) Cells Product
Table 119. Innoprot Recent Developments/Updates
Table 120. Takara Bio Company Information
Table 121. Takara Bio Description and Business Overview
Table 122. Takara Bio Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 123. Takara Bio Human 293 (HEK 293) Cells Product
Table 124. Takara Bio Recent Developments/Updates
Table 125. BPS Bioscience Company Information
Table 126. BPS Bioscience Description and Business Overview
Table 127. BPS Bioscience Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 128. BPS Bioscience Human 293 (HEK 293) Cells Product
Table 129. BPS Bioscience Recent Developments/Updates
Table 130. ACROBiosystems Group Company Information
Table 131. ACROBiosystems Group Description and Business Overview
Table 132. ACROBiosystems Group Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 133. ACROBiosystems Group Human 293 (HEK 293) Cells Product
Table 134. ACROBiosystems Group Recent Developments/Updates
Table 135. Porton Pharma Solutions Company Information
Table 136. Porton Pharma Solutions Description and Business Overview
Table 137. Porton Pharma Solutions Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 138. Porton Pharma Solutions Human 293 (HEK 293) Cells Product
Table 139. Porton Pharma Solutions Recent Developments/Updates
Table 140. Ubigene Biosciences Company Information
Table 141. Ubigene Biosciences Description and Business Overview
Table 142. Ubigene Biosciences Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 143. Ubigene Biosciences Human 293 (HEK 293) Cells Product
Table 144. Ubigene Biosciences Recent Developments/Updates
Table 145. Wuhan Pricella Biotechnology Company Information
Table 146. Wuhan Pricella Biotechnology Description and Business Overview
Table 147. Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 148. Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Product
Table 149. Wuhan Pricella Biotechnology Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Human 293 (HEK 293) Cells Distributors List
Table 153. Human 293 (HEK 293) Cells Customers List
Table 154. Human 293 (HEK 293) Cells Market Trends
Table 155. Human 293 (HEK 293) Cells Market Drivers
Table 156. Human 293 (HEK 293) Cells Market Challenges
Table 157. Human 293 (HEK 293) Cells Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human 293 (HEK 293) Cells
Figure 2. Global Human 293 (HEK 293) Cells Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human 293 (HEK 293) Cells Market Share by Type: 2024 & 2031
Figure 4. HEK293T Product Picture
Figure 5. HEK293E Product Picture
Figure 6. HEK293F Product Picture
Figure 7. HEK293S Product Picture
Figure 8. Others Product Picture
Figure 9. Global Human 293 (HEK 293) Cells Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Human 293 (HEK 293) Cells Market Share by Application: 2024 & 2031
Figure 11. Recombinant Protein Production
Figure 12. Gene Therapy
Figure 13. Vaccine Development
Figure 14. Drug Screening
Figure 15. Others
Figure 16. Global Human 293 (HEK 293) Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Human 293 (HEK 293) Cells Market Size (2020-2031) & (US$ Million)
Figure 18. Global Human 293 (HEK 293) Cells Sales (2020-2031) & (K Vials)
Figure 19. Global Human 293 (HEK 293) Cells Average Price (US$/Vials) & (2020-2031)
Figure 20. Human 293 (HEK 293) Cells Report Years Considered
Figure 21. Human 293 (HEK 293) Cells Sales Share by Manufacturers in 2024
Figure 22. Global Human 293 (HEK 293) Cells Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Human 293 (HEK 293) Cells Players: Market Share by Revenue in Human 293 (HEK 293) Cells in 2024
Figure 24. Human 293 (HEK 293) Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Human 293 (HEK 293) Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 27. North America Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 28. United States Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 31. Europe Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 32. Germany Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Human 293 (HEK 293) Cells Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Human 293 (HEK 293) Cells Revenue Market Share by Region (2020-2031)
Figure 39. China Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 47. Latin America Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Colombia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Human 293 (HEK 293) Cells by Type (2020-2031)
Figure 58. Global Revenue Market Share of Human 293 (HEK 293) Cells by Type (2020-2031)
Figure 59. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Type (2020-2031)
Figure 60. Global Sales Market Share of Human 293 (HEK 293) Cells by Application (2020-2031)
Figure 61. Global Revenue Market Share of Human 293 (HEK 293) Cells by Application (2020-2031)
Figure 62. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Application (2020-2031)
Figure 63. Human 293 (HEK 293) Cells Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Human 293 (HEK 293) Cells Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human 293 (HEK 293) Cells Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human 293 (HEK 293) Cells Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human 293 (HEK 293) Cells Sales (K Vials) of Key Manufacturers (2020-2025)
Table 5. Global Human 293 (HEK 293) Cells Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human 293 (HEK 293) Cells Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human 293 (HEK 293) Cells Average Price (US$/Vials) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human 293 (HEK 293) Cells, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human 293 (HEK 293) Cells, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human 293 (HEK 293) Cells, Product Type & Application
Table 12. Global Key Manufacturers of Human 293 (HEK 293) Cells, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human 293 (HEK 293) Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human 293 (HEK 293) Cells as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human 293 (HEK 293) Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human 293 (HEK 293) Cells Sales by Region (2020-2025) & (K Vials)
Table 18. Global Human 293 (HEK 293) Cells Sales Market Share by Region (2020-2025)
Table 19. Global Human 293 (HEK 293) Cells Sales by Region (2026-2031) & (K Vials)
Table 20. Global Human 293 (HEK 293) Cells Sales Market Share by Region (2026-2031)
Table 21. Global Human 293 (HEK 293) Cells Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human 293 (HEK 293) Cells Revenue Market Share by Region (2020-2025)
Table 23. Global Human 293 (HEK 293) Cells Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human 293 (HEK 293) Cells Revenue Market Share by Region (2026-2031)
Table 25. North America Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 27. North America Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 28. North America Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 32. Europe Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 33. Europe Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human 293 (HEK 293) Cells Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human 293 (HEK 293) Cells Sales by Region (2020-2025) & (K Vials)
Table 37. Asia Pacific Human 293 (HEK 293) Cells Sales by Region (2026-2031) & (K Vials)
Table 38. Asia Pacific Human 293 (HEK 293) Cells Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human 293 (HEK 293) Cells Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 42. Latin America Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 43. Latin America Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human 293 (HEK 293) Cells Sales by Country (2020-2025) & (K Vials)
Table 47. Middle East and Africa Human 293 (HEK 293) Cells Sales by Country (2026-2031) & (K Vials)
Table 48. Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human 293 (HEK 293) Cells Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human 293 (HEK 293) Cells Sales (K Vials) by Type (2020-2025)
Table 51. Global Human 293 (HEK 293) Cells Sales (K Vials) by Type (2026-2031)
Table 52. Global Human 293 (HEK 293) Cells Sales Market Share by Type (2020-2025)
Table 53. Global Human 293 (HEK 293) Cells Sales Market Share by Type (2026-2031)
Table 54. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human 293 (HEK 293) Cells Revenue Market Share by Type (2020-2025)
Table 57. Global Human 293 (HEK 293) Cells Revenue Market Share by Type (2026-2031)
Table 58. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Type (2020-2025)
Table 59. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Type (2026-2031)
Table 60. Global Human 293 (HEK 293) Cells Sales (K Vials) by Application (2020-2025)
Table 61. Global Human 293 (HEK 293) Cells Sales (K Vials) by Application (2026-2031)
Table 62. Global Human 293 (HEK 293) Cells Sales Market Share by Application (2020-2025)
Table 63. Global Human 293 (HEK 293) Cells Sales Market Share by Application (2026-2031)
Table 64. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human 293 (HEK 293) Cells Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human 293 (HEK 293) Cells Revenue Market Share by Application (2020-2025)
Table 67. Global Human 293 (HEK 293) Cells Revenue Market Share by Application (2026-2031)
Table 68. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Application (2020-2025)
Table 69. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Application (2026-2031)
Table 70. Altogen Biosystems Company Information
Table 71. Altogen Biosystems Description and Business Overview
Table 72. Altogen Biosystems Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 73. Altogen Biosystems Human 293 (HEK 293) Cells Product
Table 74. Altogen Biosystems Recent Developments/Updates
Table 75. ATCC Company Information
Table 76. ATCC Description and Business Overview
Table 77. ATCC Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 78. ATCC Human 293 (HEK 293) Cells Product
Table 79. ATCC Recent Developments/Updates
Table 80. Synthego Company Information
Table 81. Synthego Description and Business Overview
Table 82. Synthego Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 83. Synthego Human 293 (HEK 293) Cells Product
Table 84. Synthego Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Human 293 (HEK 293) Cells Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Beckman Coulter Company Information
Table 91. Beckman Coulter Description and Business Overview
Table 92. Beckman Coulter Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 93. Beckman Coulter Human 293 (HEK 293) Cells Product
Table 94. Beckman Coulter Recent Developments/Updates
Table 95. Sigma Aldrich Company Information
Table 96. Sigma Aldrich Description and Business Overview
Table 97. Sigma Aldrich Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 98. Sigma Aldrich Human 293 (HEK 293) Cells Product
Table 99. Sigma Aldrich Recent Developments/Updates
Table 100. Promega Company Information
Table 101. Promega Description and Business Overview
Table 102. Promega Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 103. Promega Human 293 (HEK 293) Cells Product
Table 104. Promega Recent Developments/Updates
Table 105. Kerafast Company Information
Table 106. Kerafast Description and Business Overview
Table 107. Kerafast Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 108. Kerafast Human 293 (HEK 293) Cells Product
Table 109. Kerafast Recent Developments/Updates
Table 110. InvivoGen Company Information
Table 111. InvivoGen Description and Business Overview
Table 112. InvivoGen Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 113. InvivoGen Human 293 (HEK 293) Cells Product
Table 114. InvivoGen Recent Developments/Updates
Table 115. Innoprot Company Information
Table 116. Innoprot Description and Business Overview
Table 117. Innoprot Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 118. Innoprot Human 293 (HEK 293) Cells Product
Table 119. Innoprot Recent Developments/Updates
Table 120. Takara Bio Company Information
Table 121. Takara Bio Description and Business Overview
Table 122. Takara Bio Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 123. Takara Bio Human 293 (HEK 293) Cells Product
Table 124. Takara Bio Recent Developments/Updates
Table 125. BPS Bioscience Company Information
Table 126. BPS Bioscience Description and Business Overview
Table 127. BPS Bioscience Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 128. BPS Bioscience Human 293 (HEK 293) Cells Product
Table 129. BPS Bioscience Recent Developments/Updates
Table 130. ACROBiosystems Group Company Information
Table 131. ACROBiosystems Group Description and Business Overview
Table 132. ACROBiosystems Group Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 133. ACROBiosystems Group Human 293 (HEK 293) Cells Product
Table 134. ACROBiosystems Group Recent Developments/Updates
Table 135. Porton Pharma Solutions Company Information
Table 136. Porton Pharma Solutions Description and Business Overview
Table 137. Porton Pharma Solutions Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 138. Porton Pharma Solutions Human 293 (HEK 293) Cells Product
Table 139. Porton Pharma Solutions Recent Developments/Updates
Table 140. Ubigene Biosciences Company Information
Table 141. Ubigene Biosciences Description and Business Overview
Table 142. Ubigene Biosciences Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 143. Ubigene Biosciences Human 293 (HEK 293) Cells Product
Table 144. Ubigene Biosciences Recent Developments/Updates
Table 145. Wuhan Pricella Biotechnology Company Information
Table 146. Wuhan Pricella Biotechnology Description and Business Overview
Table 147. Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Sales (K Vials), Revenue (US$ Million), Price (US$/Vials) and Gross Margin (2020-2025)
Table 148. Wuhan Pricella Biotechnology Human 293 (HEK 293) Cells Product
Table 149. Wuhan Pricella Biotechnology Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Human 293 (HEK 293) Cells Distributors List
Table 153. Human 293 (HEK 293) Cells Customers List
Table 154. Human 293 (HEK 293) Cells Market Trends
Table 155. Human 293 (HEK 293) Cells Market Drivers
Table 156. Human 293 (HEK 293) Cells Market Challenges
Table 157. Human 293 (HEK 293) Cells Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human 293 (HEK 293) Cells
Figure 2. Global Human 293 (HEK 293) Cells Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human 293 (HEK 293) Cells Market Share by Type: 2024 & 2031
Figure 4. HEK293T Product Picture
Figure 5. HEK293E Product Picture
Figure 6. HEK293F Product Picture
Figure 7. HEK293S Product Picture
Figure 8. Others Product Picture
Figure 9. Global Human 293 (HEK 293) Cells Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Human 293 (HEK 293) Cells Market Share by Application: 2024 & 2031
Figure 11. Recombinant Protein Production
Figure 12. Gene Therapy
Figure 13. Vaccine Development
Figure 14. Drug Screening
Figure 15. Others
Figure 16. Global Human 293 (HEK 293) Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Human 293 (HEK 293) Cells Market Size (2020-2031) & (US$ Million)
Figure 18. Global Human 293 (HEK 293) Cells Sales (2020-2031) & (K Vials)
Figure 19. Global Human 293 (HEK 293) Cells Average Price (US$/Vials) & (2020-2031)
Figure 20. Human 293 (HEK 293) Cells Report Years Considered
Figure 21. Human 293 (HEK 293) Cells Sales Share by Manufacturers in 2024
Figure 22. Global Human 293 (HEK 293) Cells Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Human 293 (HEK 293) Cells Players: Market Share by Revenue in Human 293 (HEK 293) Cells in 2024
Figure 24. Human 293 (HEK 293) Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Human 293 (HEK 293) Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 27. North America Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 28. United States Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 31. Europe Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 32. Germany Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Human 293 (HEK 293) Cells Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Human 293 (HEK 293) Cells Revenue Market Share by Region (2020-2031)
Figure 39. China Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 47. Latin America Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Colombia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Human 293 (HEK 293) Cells Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Human 293 (HEK 293) Cells Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Human 293 (HEK 293) Cells Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Human 293 (HEK 293) Cells by Type (2020-2031)
Figure 58. Global Revenue Market Share of Human 293 (HEK 293) Cells by Type (2020-2031)
Figure 59. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Type (2020-2031)
Figure 60. Global Sales Market Share of Human 293 (HEK 293) Cells by Application (2020-2031)
Figure 61. Global Revenue Market Share of Human 293 (HEK 293) Cells by Application (2020-2031)
Figure 62. Global Human 293 (HEK 293) Cells Price (US$/Vials) by Application (2020-2031)
Figure 63. Human 293 (HEK 293) Cells Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Chipping Hammer Market Research Report 2025
Aug 26, 25
Global Height Control Valve Market Research Report 2025
Aug 26, 25
Global Automatic Drain Valve Market Research Report 2025
Aug 26, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232